| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 3.35e-05 | 2 | 116 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor activity | 1.99e-04 | 4 | 116 | 2 | GO:0004939 | |
| GeneOntologyMolecularFunction | hyaluronan synthase activity | 1.99e-04 | 4 | 116 | 2 | GO:0050501 | |
| GeneOntologyBiologicalProcess | aminoglycan biosynthetic process | 7.59e-06 | 80 | 121 | 6 | GO:0006023 | |
| GeneOntologyBiologicalProcess | aminoglycan metabolic process | 1.29e-05 | 132 | 121 | 7 | GO:0006022 | |
| GeneOntologyBiologicalProcess | mucopolysaccharide metabolic process | 2.74e-05 | 100 | 121 | 6 | GO:1903510 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan metabolic process | 7.98e-05 | 121 | 121 | 6 | GO:0030203 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan biosynthetic process | 8.47e-05 | 76 | 121 | 5 | GO:0006024 | |
| GeneOntologyBiologicalProcess | norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure | 1.02e-04 | 3 | 121 | 2 | GO:0002025 | |
| Domain | Alg10 | 4.03e-05 | 2 | 119 | 2 | IPR016900 | |
| Domain | Med12 | 4.03e-05 | 2 | 119 | 2 | PF09497 | |
| Domain | Mediator_Med12_catenin-bd | 4.03e-05 | 2 | 119 | 2 | IPR021989 | |
| Domain | Med12-PQL | 4.03e-05 | 2 | 119 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 4.03e-05 | 2 | 119 | 2 | PF12145 | |
| Domain | Med12 | 4.03e-05 | 2 | 119 | 2 | SM01281 | |
| Domain | Mediator_Med12 | 4.03e-05 | 2 | 119 | 2 | IPR019035 | |
| Domain | DIE2_ALG10 | 4.03e-05 | 2 | 119 | 2 | PF04922 | |
| Domain | Mediator_Med12_LCEWAV | 4.03e-05 | 2 | 119 | 2 | IPR021990 | |
| Domain | HAS/NodC | 1.20e-04 | 3 | 119 | 2 | IPR026107 | |
| Domain | Requiem/DPF_N_dom | 1.20e-04 | 3 | 119 | 2 | IPR025750 | |
| Domain | Requiem_N | 1.20e-04 | 3 | 119 | 2 | PF14051 | |
| Domain | DHC_N1 | 1.10e-03 | 8 | 119 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.10e-03 | 8 | 119 | 2 | IPR013594 | |
| Domain | ADR_fam | 1.75e-03 | 10 | 119 | 2 | IPR002233 | |
| Domain | AAA | 2.30e-03 | 144 | 119 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 2.30e-03 | 144 | 119 | 5 | IPR003593 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.48e-03 | 14 | 119 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.48e-03 | 14 | 119 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.48e-03 | 14 | 119 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.48e-03 | 14 | 119 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.48e-03 | 14 | 119 | 2 | IPR011704 | |
| Domain | MT | 3.48e-03 | 14 | 119 | 2 | PF12777 | |
| Domain | AAA_8 | 3.48e-03 | 14 | 119 | 2 | PF12780 | |
| Domain | AAA_5 | 3.48e-03 | 14 | 119 | 2 | PF07728 | |
| Domain | DHC_fam | 4.00e-03 | 15 | 119 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.00e-03 | 15 | 119 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.00e-03 | 15 | 119 | 2 | IPR004273 | |
| Domain | GRAM | 4.56e-03 | 16 | 119 | 2 | SM00568 | |
| Domain | Galactosyl_T | 4.56e-03 | 16 | 119 | 2 | PF01762 | |
| Domain | Glyco_trans_31 | 4.56e-03 | 16 | 119 | 2 | IPR002659 | |
| Domain | Gal_mutarotase_SF_dom | 5.14e-03 | 17 | 119 | 2 | IPR011013 | |
| Pubmed | 1.14e-05 | 604 | 124 | 11 | 38803224 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21850020 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 29587766 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 1684419 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 14724275 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 16631628 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 36063901 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24658508 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12196544 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18826941 | ||
| Pubmed | Knockout of hyaluronan synthase 1, but not 3, impairs formation of the retrocalcaneal bursa. | 1.26e-05 | 2 | 124 | 2 | 29672913 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24972470 | ||
| Pubmed | Structure and expression of two members of the d4 gene family in mouse. | 1.26e-05 | 2 | 124 | 2 | 10602997 | |
| Pubmed | Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling. | 1.26e-05 | 2 | 124 | 2 | 22306453 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26769900 | ||
| Pubmed | 2.39e-05 | 16 | 124 | 3 | 33454424 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 15079793 | ||
| Pubmed | Expression of hyaluronan synthase genes in umbilical cord blood stem/progenitor cells. | 3.77e-05 | 3 | 124 | 2 | 16564133 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 18801900 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 18765789 | ||
| Pubmed | Mammalian hyaluronan synthases: investigation of functional relationships in vivo. | 3.77e-05 | 3 | 124 | 2 | 10093717 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 28752049 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 24885710 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 15932670 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 8812431 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 27289075 | ||
| Pubmed | Trp64Arg polymorphism in ADRB3 gene is associated with elite endurance performance. | 3.77e-05 | 3 | 124 | 2 | 19553224 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 24303013 | ||
| Pubmed | Hyaluronan Regulates Eyelid and Meibomian Gland Morphogenesis. | 3.77e-05 | 3 | 124 | 2 | 30046813 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 16786194 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 12766172 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 25795779 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 34483955 | ||
| Pubmed | Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3. | 3.77e-05 | 3 | 124 | 2 | 23303191 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 15479221 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 28177749 | ||
| Pubmed | betaAR signaling required for diet-induced thermogenesis and obesity resistance. | 3.77e-05 | 3 | 124 | 2 | 12161655 | |
| Pubmed | Role of β-adrenoceptors in glucose uptake in astrocytes using β-adrenoceptor knockout mice. | 3.77e-05 | 3 | 124 | 2 | 21138422 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 26566631 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 23473322 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 18239290 | ||
| Pubmed | Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice. | 3.77e-05 | 3 | 124 | 2 | 15939797 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 22654110 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 11790779 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 15464701 | ||
| Pubmed | Control of 4E-BP1 expression in mouse brown adipose tissue by the beta3-adrenoceptor. | 3.77e-05 | 3 | 124 | 2 | 15474034 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 19420258 | ||
| Pubmed | Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. | 3.77e-05 | 3 | 124 | 2 | 11431361 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 17345787 | ||
| Pubmed | [Association of beta-adrenoceptor gene polymorphism with resting heart rate]. | 3.77e-05 | 3 | 124 | 2 | 17591269 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 16767221 | ||
| Pubmed | Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. | 3.77e-05 | 3 | 124 | 2 | 10455188 | |
| Pubmed | A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. | 3.77e-05 | 3 | 124 | 2 | 11854867 | |
| Pubmed | Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. | 3.77e-05 | 3 | 124 | 2 | 9442026 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 15833937 | ||
| Pubmed | Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. | 3.77e-05 | 3 | 124 | 2 | 18311486 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 24790187 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 11737201 | ||
| Pubmed | Perturbation of hyaluronan synthesis in the trabecular meshwork and the effects on outflow facility. | 3.77e-05 | 3 | 124 | 2 | 22695958 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 15765504 | ||
| Pubmed | Hyaluronan Modulates the Biomechanical Properties of the Cornea. | 3.77e-05 | 3 | 124 | 2 | 36478198 | |
| Pubmed | Hyaluronan Derived From the Limbus is a Key Regulator of Corneal Lymphangiogenesis. | 3.77e-05 | 3 | 124 | 2 | 30897620 | |
| Pubmed | Expression of β-adrenergic receptor subtypes in human normal and dilated ureter. | 3.77e-05 | 3 | 124 | 2 | 28756611 | |
| Pubmed | Association of beta-adrenoceptor single nucleotide polymorphisms with resting heart rate. | 3.77e-05 | 3 | 124 | 2 | 17270896 | |
| Pubmed | Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors. | 3.77e-05 | 3 | 124 | 2 | 10358009 | |
| Pubmed | Diverse evolutionary histories for beta-adrenoreceptor genes in humans. | 3.77e-05 | 3 | 124 | 2 | 19576569 | |
| Pubmed | Expression of beta adrenergic receptors in mouse oocytes and preimplantation embryos. | 3.77e-05 | 3 | 124 | 2 | 15791602 | |
| Pubmed | Total beta-adrenoceptor deficiency results in cardiac hypotrophy and negative inotropy. | 3.77e-05 | 3 | 124 | 2 | 20406048 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 12387862 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 7738011 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 21366703 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 21878665 | ||
| Pubmed | Analysis of hyaluronic acid in the endometrium of women with polycystic ovary syndrome. | 3.77e-05 | 3 | 124 | 2 | 30614308 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 23133676 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 10617644 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 15917856 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 9206724 | ||
| Pubmed | Expression regulation of hyaluronan synthase in corneal endothelial cells. | 3.77e-05 | 3 | 124 | 2 | 11006212 | |
| Pubmed | Tissue distribution and subcellular localization of hyaluronan synthase isoenzymes. | 3.77e-05 | 3 | 124 | 2 | 24057227 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 33183171 | ||
| Pubmed | Hyaluronan in cervical epithelia protects against infection-mediated preterm birth. | 7.53e-05 | 4 | 124 | 2 | 25384213 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 7579515 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 14695357 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 29715048 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 27206969 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 28863216 | ||
| Pubmed | The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. | 7.53e-05 | 4 | 124 | 2 | 14525949 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 17446185 | ||
| Pubmed | Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. | 7.53e-05 | 4 | 124 | 2 | 17512307 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 23129777 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 18331634 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 20144152 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 21976502 | ||
| Pubmed | Dynamic states of cervical epithelia during pregnancy and epithelial barrier disruption. | 7.53e-05 | 4 | 124 | 2 | 36718364 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 23560496 | ||
| Pubmed | Vagal tone dominates autonomic control of mouse heart rate at thermoneutrality. | 7.53e-05 | 4 | 124 | 2 | 18245567 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 9457904 | ||
| Pubmed | Receptor tyrosine kinase gene Tyro3 maps to mouse chromosome 2, closely linked to Ltk. | 7.53e-05 | 4 | 124 | 2 | 8661736 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 20203292 | ||
| Pubmed | The control and importance of hyaluronan synthase expression in palatogenesis. | 7.53e-05 | 4 | 124 | 2 | 23382716 | |
| GeneFamily | Alpha-1,2-glucosyltransferases | 2.40e-05 | 2 | 89 | 2 | 448 | |
| GeneFamily | Glycosyltransferase family 2 | 3.55e-04 | 6 | 89 | 2 | 428 | |
| GeneFamily | Adrenoceptors | 8.43e-04 | 9 | 89 | 2 | 169 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 1.80e-03 | 13 | 89 | 2 | 1146 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 1.49e-08 | 159 | 123 | 8 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-07 | 154 | 123 | 7 | ee03b386d28a524084eaf1c0091f7389daa34250 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-07 | 154 | 123 | 7 | 3fa6f77ad2c30ec24b9b904e2732ec5b419dff5b | |
| ToppCell | Striatum-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Dkk3_(Deep_layer_cortex)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.74e-07 | 114 | 123 | 6 | 3352ce794a646e3e7f15a991dd8a847a3c705394 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN1(Slc17a7)|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.74e-07 | 114 | 123 | 6 | 158dc333b337d5e83183b2f010a8e030c7a57bc7 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Dkk3_(Deep_layer_cortex)|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.74e-07 | 114 | 123 | 6 | 238f2541e0514df8d24d767f833980d770b920a4 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.74e-07 | 114 | 123 | 6 | e63c0ebf843392c2926732bb8792eb6ee69bec15 | |
| ToppCell | Severe-B_naive-9|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.46e-06 | 139 | 123 | 6 | b9b049953958f15d773eb5cca6d5dc34f4829543 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-06 | 160 | 123 | 6 | cfd005e98944817458e8ef9e0c436d77f50c1ad1 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-06 | 164 | 123 | 6 | 54f8f11d2fa899005530c08e7a1ee728c7b0799c | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.59e-06 | 169 | 123 | 6 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-05 | 178 | 123 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_(gd)|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.09e-05 | 180 | 123 | 6 | 44c37644973c4fc555dc966f8cfe1f4f81fef300 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 181 | 123 | 6 | 14faef1dde781d501834379f2a6413e8d6a80b72 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.16e-05 | 182 | 123 | 6 | 6bd48c5d60a259719f65cacee4b8135247e78fa9 | |
| ToppCell | severe-B_naive|World / disease stage, cell group and cell class | 1.48e-05 | 190 | 123 | 6 | 8dfe067d75573289299a5fba42b6c9b26e5fb430 | |
| ToppCell | COVID-19_Moderate-pDC|World / disease group, cell group and cell class | 1.52e-05 | 191 | 123 | 6 | 93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9 | |
| ToppCell | normal_Lung-Epithelial_cells-AT2|normal_Lung / Location, Cell class and cell subclass | 1.62e-05 | 193 | 123 | 6 | 80ad1bdc50ecb8a50362f718248441cae20904a6 | |
| ToppCell | ILEUM-inflamed-(6)_ILC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.66e-05 | 194 | 123 | 6 | 4d51d49366c34ff1241770b4acc0167a43b3155a | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Tregs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.66e-05 | 194 | 123 | 6 | 0396457834bbfed8d0b9b2ddaaecd9f28e1d56ed | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue | 1.71e-05 | 195 | 123 | 6 | b748cb15846345363e8c2ee5936bb42bba3ba9a7 | |
| ToppCell | mild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-05 | 197 | 123 | 6 | 0cb00daa6943f7a7fb34a8fdf51188646af65686 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-05 | 197 | 123 | 6 | 6f83fc049f38f3de6bc5180ad4b51ceb4d5dcdb6 | |
| ToppCell | BAL-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-05 | 197 | 123 | 6 | 6ac50c02899531a25885749d5305da788dfa9dbc | |
| ToppCell | mild-pDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.81e-05 | 197 | 123 | 6 | 15230a54fa5903dd728de1a0ad633bd2d2c7a04d | |
| ToppCell | Control|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.87e-05 | 198 | 123 | 6 | 73694b6109c1f6878b6b5997e434bbc3cec1dc70 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-05 | 199 | 123 | 6 | 6dc446a5d183b01bdf227e45bd88d0b3d8b1c56a | |
| ToppCell | distal-3-Epithelial-Signaling_Alveolar_Epithelial_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.97e-05 | 200 | 123 | 6 | a77087a393aad674d4aa457ca6c0077b0424053d | |
| ToppCell | Caecum-(1)_T_cell-(17)_gd_T|Caecum / shred on region, Cell_type, and subtype | 1.97e-05 | 200 | 123 | 6 | 2aaa6b37e9f8d95de53f284a42a3ac14e6351b40 | |
| ToppCell | Caecum-T_cell-gd_T|Caecum / Region, Cell class and subclass | 1.97e-05 | 200 | 123 | 6 | eaacd14b6d4a1c7d52deab110ed3a6c7d3dc1f8e | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Proliferative_Immature_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.67e-05 | 135 | 123 | 5 | ed0f94d3839eea3b60217c4352159ed481361f13 | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.69e-05 | 148 | 123 | 5 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | Control-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.69e-05 | 148 | 123 | 5 | 662c057030effc9eb61216e81d3967e6983c244f | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-05 | 155 | 123 | 5 | efe69145910c5e049d0ed30699c26ef963e0a285 | |
| ToppCell | droplet-Fat-Scat-21m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 161 | 123 | 5 | e52735f955f0a53da5cbe5a2d77a00484e5109b3 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.73e-05 | 162 | 123 | 5 | 59f6a9005c4f22f084c25ea36f3cacce5144a9ae | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.52e-05 | 165 | 123 | 5 | 953c8242a81a39ade63ac8e5b34fe58575771746 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.52e-05 | 165 | 123 | 5 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.52e-05 | 165 | 123 | 5 | ec16a4979b3f203c9f66ed387a7a17bf3a1d3f86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.52e-05 | 165 | 123 | 5 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.52e-05 | 165 | 123 | 5 | c39f0479955c4e23921f7a450d3bc251a002200f | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.93e-05 | 87 | 123 | 4 | 8ca87e4a332ef6f035b13e80dcc0110f32172c9a | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.93e-05 | 87 | 123 | 4 | 4ec3a9489981ed69061c1ca363271edf6a3635d2 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 167 | 123 | 5 | 4a669eafde3582a451614ad304769b47aa1d9578 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 168 | 123 | 5 | 2765d98f0b7f6861d662937535e051d41dba3500 | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 168 | 123 | 5 | 5a2e7a52b7330dce30823695a7b9b26bc47a69ce | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 168 | 123 | 5 | b4b73f3fc9f4c3d87ca0a63ff8b2842141ccd0e6 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 169 | 123 | 5 | ae85cef7ef8f761c19f4af2a23fe333641c38a92 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 169 | 123 | 5 | c01bc3f2f299109086ded83dc11e98559bf1940c | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-CLP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 170 | 123 | 5 | 8d6419ffe7dc1a0483c174d8e4b29704895eb9cf | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-04 | 171 | 123 | 5 | 41932c9e70829ee3d55ca5fdb74d290fc8229416 | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.19e-04 | 173 | 123 | 5 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | ILEUM-inflamed-(1)_T_(gd)|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.19e-04 | 173 | 123 | 5 | 85c3e227c81c6ab70148639381389fba3ac5e088 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 174 | 123 | 5 | 723848d2f8ae9cf4f15d4b4a130f9a64dab443c7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 175 | 123 | 5 | 2f43883d7c89f09b0579a390a7431f1f9b832582 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 175 | 123 | 5 | da92eb8af0c7c65fed4a1d960708240f35dd997d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 176 | 123 | 5 | dbc4f64cd39b229f2355ca1d0215cc7f6a767dce | |
| ToppCell | Healthy_Control-Lymphoid-T-Treg|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.29e-04 | 176 | 123 | 5 | 7765a5b04ac117d525201f8eb08e1754e55942ff | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-B_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 177 | 123 | 5 | f4afe10522eed77318954210224496f09d372532 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 177 | 123 | 5 | f10f77130dbb2c0ad1b436ceb4fb1deac2b0267c | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-04 | 177 | 123 | 5 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | (1)_T_regulatory|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.32e-04 | 177 | 123 | 5 | 5cda56b10df1ee8971ce8470d52062e01b703a4e | |
| ToppCell | Healthy_Control-Lymphoid-NK-NK|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.36e-04 | 178 | 123 | 5 | 71e99f143009b2d29cb47b96393b58b514c8cfc6 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|normal_Lymph_Node / Location, Cell class and cell subclass | 1.39e-04 | 179 | 123 | 5 | 3dc929a10381b7d86650c6cd8f354892fe1d93e7 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 180 | 123 | 5 | ca7c316027e31559103b2cab1a2c0de993e42e95 | |
| ToppCell | Severe-Lymphoid-B|Severe / Condition, Lineage, Cell class and cell subclass | 1.43e-04 | 180 | 123 | 5 | 67ffaf5096f025c3c61fffe52f6c8a96f120fc6f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 180 | 123 | 5 | eb26ba86fba26899e54c448afc25382ddc853013 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.43e-04 | 180 | 123 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Severe-Lymphoid-B-|Severe / Condition, Lineage, Cell class and cell subclass | 1.43e-04 | 180 | 123 | 5 | fd3eb751704b14ff1500e4bd041441644d233e9c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-04 | 180 | 123 | 5 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-04 | 181 | 123 | 5 | ee1c5af8ed75dd8a0ed3152ba5b9a42d2a8c2ae4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 181 | 123 | 5 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 181 | 123 | 5 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 1.47e-04 | 181 | 123 | 5 | 3d7f089fb434fbc989f1fa159e22133ae00b2487 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.47e-04 | 181 | 123 | 5 | 070ae3f3fe0e177fabcf34e64a0f158b01354837 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 181 | 123 | 5 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-04 | 183 | 123 | 5 | 82fe14fc7039415de41bdfd615a1380bed99f560 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 183 | 123 | 5 | b9e14199abc13a4873a77d23be1a37b0d4599b0f | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 183 | 123 | 5 | 4a1e5bf58d2acd9dbceeef538b6851c1e5e91059 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-04 | 184 | 123 | 5 | 8e5fc2bdd3071e782aa8c56b8a39f8ea8f03f623 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-04 | 185 | 123 | 5 | 05e6eb78ead81268c1656e7ffe34f9cb7329b908 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.63e-04 | 185 | 123 | 5 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | control-Myeloid-pDC|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.67e-04 | 186 | 123 | 5 | fe31e9cf4575ee40b50489593c51d8c36c3cc532 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.67e-04 | 186 | 123 | 5 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 186 | 123 | 5 | a8fcb440d88770f95678c5d28413fc4d847f42a8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-04 | 186 | 123 | 5 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.67e-04 | 186 | 123 | 5 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.67e-04 | 186 | 123 | 5 | fccee4cfcc887358cf916d974f29627095b5ad9c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-04 | 186 | 123 | 5 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 186 | 123 | 5 | 6b2d15e2756d4d4d68ad600e4a6c074edc3488f2 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.67e-04 | 186 | 123 | 5 | d7d884ff4184636081c350d29f797bd923c6a3b4 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-04 | 186 | 123 | 5 | 722da08cd978249a19855fd3ec8ddda780c99d83 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.67e-04 | 186 | 123 | 5 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.67e-04 | 186 | 123 | 5 | b099cb0902e9afb11218d70407d3cab212343c6d | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-04 | 187 | 123 | 5 | 60c2576f31a60f819deb9ec500d1f714b469df4e | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.71e-04 | 187 | 123 | 5 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.75e-04 | 188 | 123 | 5 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.75e-04 | 188 | 123 | 5 | 89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.75e-04 | 188 | 123 | 5 | ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-04 | 188 | 123 | 5 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| Drug | AC1L98DX | 1.70e-06 | 38 | 121 | 5 | CID000439957 | |
| Drug | oxprenolol | 1.20e-05 | 9 | 121 | 3 | CID000004631 | |
| Drug | cimaterol | 1.63e-05 | 29 | 121 | 4 | CID000002755 | |
| Drug | 8-amino-cADPR | 2.34e-05 | 11 | 121 | 3 | CID003081323 | |
| Drug | AC1O3SYO | 2.80e-05 | 2 | 121 | 2 | CID005489529 | |
| Drug | Bupranolol | 2.80e-05 | 2 | 121 | 2 | ctd:D002046 | |
| Drug | befunolol | 4.03e-05 | 13 | 121 | 3 | CID000002309 | |
| Drug | amosulalol | 6.36e-05 | 15 | 121 | 3 | CID000002169 | |
| Drug | HV723 | 6.36e-05 | 15 | 121 | 3 | CID003081094 | |
| Drug | pyridine hemochrome | 7.27e-05 | 42 | 121 | 4 | CID000188327 | |
| Drug | poly(methylmethacrylate | 7.80e-05 | 16 | 121 | 3 | CID000522750 | |
| Drug | arbutamine | 8.37e-05 | 3 | 121 | 2 | ctd:C076559 | |
| Drug | N-(3-hydroxy-1-(naphthalen-1-yl)-1,8,11-trioxa-5-azatridecan-13-yl)-6-(2-(2-(4,4-difluoro-4,4a-dihydro-5-(thiophen-2-yl)-4-bora-3a,4a-diaza-s-indacene-3-yl)vinyl)phenoxyacetamido)hexanamide | 8.37e-05 | 3 | 121 | 2 | ctd:C568515 | |
| Drug | 3-iodopindolol | 8.37e-05 | 3 | 121 | 2 | CID000123825 | |
| Drug | p-azidobenzylcarazolol | 8.37e-05 | 3 | 121 | 2 | CID000133262 | |
| Drug | Fenoterol | 8.37e-05 | 3 | 121 | 2 | DB01288 | |
| Drug | LCB 2183 | 8.37e-05 | 3 | 121 | 2 | CID000133046 | |
| Drug | U-43,465F | 8.37e-05 | 3 | 121 | 2 | CID000134388 | |
| Drug | Arbutamine | 8.37e-05 | 3 | 121 | 2 | DB01102 | |
| Drug | broxaterol | 8.37e-05 | 3 | 121 | 2 | ctd:C045916 | |
| Drug | pBABC | 8.37e-05 | 3 | 121 | 2 | CID000126676 | |
| Drug | EXP063 | 8.37e-05 | 3 | 121 | 2 | CID003037493 | |
| Drug | ICYP-azide-2 | 8.37e-05 | 3 | 121 | 2 | CID003036190 | |
| Drug | BAM-CYP | 8.37e-05 | 3 | 121 | 2 | CID000125252 | |
| Drug | butofilolol | 8.37e-05 | 3 | 121 | 2 | CID000068838 | |
| Drug | soquinolol | 8.37e-05 | 3 | 121 | 2 | CID000068811 | |
| Drug | CS 476 | 8.37e-05 | 3 | 121 | 2 | CID000100459 | |
| Drug | exaprolol | 8.37e-05 | 3 | 121 | 2 | CID000065484 | |
| Drug | AHR-9377 | 8.37e-05 | 3 | 121 | 2 | CID000054961 | |
| Drug | dicyclopropyl ketoxime | 8.37e-05 | 3 | 121 | 2 | CID000015072 | |
| Drug | 2-hydroxysebacate | 8.37e-05 | 3 | 121 | 2 | CID000128458 | |
| Drug | Oberadilol | 8.37e-05 | 3 | 121 | 2 | CID003047798 | |
| Drug | CGP-12177-NBD | 8.37e-05 | 3 | 121 | 2 | CID003081105 | |
| Drug | Bupranolol | 8.37e-05 | 3 | 121 | 2 | DB08808 | |
| Drug | p-azidoclonidine | 8.37e-05 | 3 | 121 | 2 | CID003035819 | |
| Drug | ICYP-azide-1 | 8.37e-05 | 3 | 121 | 2 | CID000133837 | |
| Drug | AC1L4W2Z | 8.37e-05 | 3 | 121 | 2 | CID000193350 | |
| Drug | H 216/44 | 8.37e-05 | 3 | 121 | 2 | CID000130141 | |
| Drug | AC1L1TT8 | 8.37e-05 | 3 | 121 | 2 | CID000060729 | |
| Drug | ADATN | 8.37e-05 | 3 | 121 | 2 | CID000133861 | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 3204_UP | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 5472_DN | |
| Drug | talinolol | 1.13e-04 | 18 | 121 | 3 | CID000068770 | |
| Drug | v315 | 1.67e-04 | 4 | 121 | 2 | CID000053925 | |
| Drug | NHNPNBE | 1.67e-04 | 4 | 121 | 2 | CID006453817 | |
| Drug | eclanamine | 1.67e-04 | 4 | 121 | 2 | CID000051228 | |
| Drug | Tobanum | 1.67e-04 | 4 | 121 | 2 | CID000065814 | |
| Drug | flestolol | 1.67e-04 | 4 | 121 | 2 | CID000055884 | |
| Drug | DAPN | 1.67e-04 | 4 | 121 | 2 | CID000125184 | |
| Drug | SOM-1122 | 1.67e-04 | 4 | 121 | 2 | CID000068918 | |
| Drug | tienoxolol | 1.67e-04 | 4 | 121 | 2 | CID000065678 | |
| Drug | Alp-NBD | 1.67e-04 | 4 | 121 | 2 | CID000126953 | |
| Drug | i 583 | 1.67e-04 | 4 | 121 | 2 | CID000072881 | |
| Drug | cyanopindolol | 1.67e-04 | 4 | 121 | 2 | ctd:C047975 | |
| Drug | acebutolol azide | 1.67e-04 | 4 | 121 | 2 | CID000133410 | |
| Drug | CGP 20712A | 1.67e-04 | 4 | 121 | 2 | ctd:C049763 | |
| Drug | iodoazidobenzylpindolol | 1.67e-04 | 4 | 121 | 2 | CID000132676 | |
| Disease | Long Qt Syndrome 2 | 5.07e-05 | 3 | 122 | 2 | C3150943 | |
| Disease | nephrotic syndrome type 20 (implicated_via_orthology) | 1.01e-04 | 4 | 122 | 2 | DOID:0070357 (implicated_via_orthology) | |
| Disease | Ovarian cyst | 1.68e-04 | 5 | 122 | 2 | HP_0000138 | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 2.52e-04 | 6 | 122 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | pantothenate measurement | 4.67e-04 | 8 | 122 | 2 | EFO_0021034 | |
| Disease | n-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 measurement | 5.99e-04 | 9 | 122 | 2 | EFO_0801817 | |
| Disease | body height at birth | 6.09e-04 | 40 | 122 | 3 | EFO_0006784 | |
| Disease | reticulocyte measurement | LCORL PIEZO1 AFF3 RFC1 PNKD PRPF8 ADRB1 ATAD2B KEL SIGLEC1 MMAB MED12 | 1.42e-03 | 1053 | 122 | 12 | EFO_0010700 |
| Disease | Birth Weight | 1.49e-03 | 14 | 122 | 2 | C0005612 | |
| Disease | clonal hematopoiesis mutation measurement | 1.55e-03 | 55 | 122 | 3 | EFO_0020949 | |
| Disease | lysophosphatidylcholine 14:0 measurement | 1.72e-03 | 15 | 122 | 2 | EFO_0010356 | |
| Disease | Astigmatism | 2.06e-03 | 129 | 122 | 4 | HP_0000483 | |
| Disease | Parkinson disease | 2.23e-03 | 321 | 122 | 6 | MONDO_0005180 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 2.48e-03 | 18 | 122 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | squamous cell carcinoma | 2.72e-03 | 67 | 122 | 3 | EFO_0000707 | |
| Disease | skin sensitivity to sun | 2.77e-03 | 19 | 122 | 2 | EFO_0004795 | |
| Disease | cataract | 2.84e-03 | 141 | 122 | 4 | MONDO_0005129 | |
| Disease | Arthrogryposis | 3.38e-03 | 21 | 122 | 2 | C0003886 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ARYCNRSADLIPLSF | 66 | Q8NFU0 | |
| QERFERCLDLYLCPR | 361 | Q14137 | |
| PICDFLELQRRYRSL | 236 | Q8N163 | |
| SLCVYEPDRNALRRK | 16 | P51826 | |
| IYCRSPDFRKAFQRL | 376 | P08588 | |
| IFLGRCAEYRALLSP | 46 | Q10588 | |
| EPRNCARRYLKVDFA | 366 | P12645 | |
| EPVSRCQRLSELYLR | 56 | O43822 | |
| LRPCFDQTVFLQRRY | 201 | Q86XJ0 | |
| YNARLCAERSLRLPF | 26 | Q92782 | |
| NYVSRPRRCELAAAL | 206 | P49640 | |
| NYVSRPRRCELAAAL | 211 | Q03828 | |
| CANPLIYLLLDRSFR | 301 | O00155 | |
| ALCNPHIQADRLRYR | 16 | Q9Y6B7 | |
| RLRLCTTLYQAPERA | 471 | Q8IYW2 | |
| ARECYRPVAARASLL | 3701 | Q96DT5 | |
| CLLFSAFSRALREPY | 21 | Q5I7T1 | |
| SRRDFLYARRLSLLC | 856 | O60423 | |
| RFQLPERGSRLCLYE | 36 | O76075 | |
| RLSRCLLLNSRYPQL | 1341 | Q96PN6 | |
| YCRSPDFRSAFRRLL | 346 | P13945 | |
| YLRDPIDLRACRVFK | 236 | O95905 | |
| ACVLRDTINPYLLRR | 731 | Q03468 | |
| IRFDQLHREYCLSPR | 436 | Q8NCD3 | |
| FFRRHGTPRRLLYCQ | 561 | P50281 | |
| GTPRRLLYCQRSLLD | 566 | P50281 | |
| AASLCLPRYSFRRLD | 266 | Q99571 | |
| TSQREYLRLLDALCP | 156 | Q86XR2 | |
| APAARAFLDAVRLYR | 236 | Q86XR2 | |
| LEAALSCPRFLRYPR | 206 | Q14296 | |
| YLLRLFAAPSRCRFL | 246 | Q9NSA2 | |
| SRRLAYFCARRLSLL | 291 | Q86YW9 | |
| YFCARRLSLLLSDSP | 296 | Q86YW9 | |
| RYSVFRPGVLLCDRQ | 161 | Q9BUP3 | |
| GESLPRSLRYCDLRL | 1036 | Q4ZG55 | |
| DENLPYDLRASFCRL | 771 | Q14643 | |
| RIPLSRFQYHLASCR | 16 | Q9H1H1 | |
| ERLRFLFNELRPAVC | 1511 | O95714 | |
| LCTEAALIALRRRYP | 616 | Q9ULI0 | |
| RAQAALYAPALRLRD | 71 | A8MQB3 | |
| YGPRLRRDLSLFEDC | 61 | Q8N3X6 | |
| SRLLSIRLPYCRENV | 296 | Q5VW00 | |
| PLFLIYCRALNSRGE | 121 | Q86SJ6 | |
| LRPSFASILERLQYC | 766 | P29376 | |
| PLLACLFENQFRRAR | 631 | P11678 | |
| YLRVPLVDRATCLRS | 371 | P00740 | |
| RLAYFCTRRLALQLD | 296 | Q93074 | |
| LAACSPYFRARFLAE | 51 | Q2TBA0 | |
| FESVRCRLLPRAFLE | 221 | Q2TBA0 | |
| ELPLFRSLLGRARCY | 106 | Q8IVL5 | |
| RDLLRYAAQLPALFR | 156 | Q8IZL8 | |
| CIYDRRFSQLSELPR | 186 | A7KAX9 | |
| LPNLLCSRFPDGRYR | 81 | P58294 | |
| LARYCLRAPFGRNLI | 96 | Q96EF6 | |
| RVILYNRTRLDCPFF | 441 | O94856 | |
| DLCLPALDYLRRCSQ | 1386 | Q5TH69 | |
| AALTLPRVQCRASRY | 26 | Q14213 | |
| REYLCLDNSARFRPH | 746 | Q9UHN6 | |
| ARLARAYRPAAAFLR | 501 | Q674R7 | |
| LRQCLASARALLYPR | 111 | Q92839 | |
| AAAPRRCLLSHYRSL | 21 | K9M1U5 | |
| VSPLYFTDCNLRGRL | 21 | Q9NTJ4 | |
| CRPNLSREVLYEIFR | 21 | Q9NS73 | |
| CAYIRSLAPSLLDRN | 21 | Q8TBQ9 | |
| HCSLVSLRFPRFYLR | 56 | P0DV60 | |
| QCLRIFGSYDPRRQI | 171 | P08311 | |
| RDLNRLPQDLYHARC | 96 | Q9H293 | |
| EDPDYLRKCLRSAQR | 96 | O00219 | |
| RRCLYASVLTAQPRL | 726 | P13639 | |
| LRRHRLRSDCFYEQP | 1496 | Q9BYK8 | |
| YPKDLRRFLLSAACR | 111 | Q7Z7M8 | |
| RFPAHRVILAARCQY | 46 | Q96Q07 | |
| DLAREAYRPCAQRAS | 3601 | Q9P225 | |
| LACFRNAIRVNPRHY | 621 | P30260 | |
| LDCRPYLAFAASNVR | 26 | Q16690 | |
| APYFRLLRLCVERQH | 731 | Q9BXW9 | |
| CFGAARLLYPRFQSR | 21 | Q96EY8 | |
| AFYCVSRDLLPFTLR | 141 | Q8TB24 | |
| NQCENIRRLPSFRRY | 361 | Q9UBD5 | |
| CYLLLVRFIADRRAA | 286 | Q9NSD7 | |
| LRADYNLTRIRPDCF | 1121 | P26640 | |
| RAKNLRRLLYVSCNP | 526 | Q8IZ69 | |
| ERSYNPFLRTHCLAL | 336 | Q8N490 | |
| LRECFRNPQFRIFAY | 151 | Q96D59 | |
| RSLVHYCFDLRFQRP | 761 | P35251 | |
| IVLRSYDACDTLRPR | 291 | Q99519 | |
| YRLTPALDSLRCRRC | 146 | Q11203 | |
| AFDQLCRLYRGSSRL | 1366 | Q8N3P4 | |
| PRARDFYRQFCVKLA | 1481 | Q7Z745 | |
| EQRFRYTCKARLADP | 726 | Q13591 | |
| KNECYRATFRLPRDE | 286 | Q66K14 | |
| TPEAKAFIRRCLAYR | 711 | Q86UE8 | |
| RCLYGALSDPIRRAL | 71 | Q969K4 | |
| NLPDRFKDFLLYLRC | 111 | Q9NY97 | |
| CLLFSAFSRALREPY | 21 | Q5BKT4 | |
| SPAEINRRLRAYLAF | 156 | Q8NET6 | |
| RFFCRRVESPALLAS | 766 | O94762 | |
| ARYLQLDAARLVRCN | 46 | Q96EP0 | |
| AAHPIRLFCRYIDRI | 1081 | Q6P2Q9 | |
| RFRLDIYRCLASPAL | 211 | P48995 | |
| IQCLRRYRDTKRAFP | 461 | Q9UBH6 | |
| FLPRGDRYDALRACI | 436 | A0AVT1 | |
| YVDSRCLANLRPLLD | 576 | A0AVT1 | |
| AARAFAQRYLADLLP | 396 | Q86UC2 | |
| DFTPNAYLARRRFQC | 86 | A8K554 | |
| ALRSLYRARPSLRCP | 6 | Q9BU61 | |
| FCLPLRRAHRYDLVN | 321 | Q658P3 | |
| YARPRFLRLQESLAT | 616 | Q5K4L6 | |
| PALNDSRYCLSSRLR | 66 | P01850 | |
| LYCPFRAEERTRQLE | 156 | Q15833 | |
| AALRRVLTAYAFRNP | 581 | Q6ZT07 | |
| FELRARYLIACERIP | 196 | Q8IZM8 | |
| AVRLLSEQTCRRFYP | 971 | Q7Z410 | |
| NYNARLCAERSVRLP | 26 | Q92785 | |
| RLRLADCLVPYSRAL | 116 | Q6PEY1 | |
| YDNRAPNTAELRICR | 176 | Q04864 | |
| LLPVARTDAALYACR | 761 | Q9BZZ2 | |
| TPERLHARRQLYAAC | 66 | Q99726 | |
| DARARARIALYSVFP | 476 | A2A288 | |
| YDFLPREPCNLALRR | 91 | P42681 | |
| CPAYLLLRYNERLDR | 76 | Q96MP5 | |
| PALNDSRYCLSSRLR | 66 | A0A5B9 | |
| RPYCRRDFLQLFAPR | 331 | O43294 | |
| CLSLAQGTYRPLRRF | 1931 | Q92508 | |
| PDCGLAFRLASYLRQ | 301 | Q8NAF0 | |
| CPRRFSRAYSLLRHQ | 446 | Q8NAF0 | |
| NSYQIRREFLLPACL | 41 | Q5T7P6 | |
| RDLVPATNYSLRVRC | 286 | Q06418 | |
| NSAADPDYCRRILVR | 66 | Q5SQQ9 | |
| FARYFRCARGALLNP | 711 | P23276 |